Prostate Cancer

Watchful waiting has become a byword for prostate-cancer patients, most of whom won’t need aggressive surgery to remove their slow growing tumors. But doctors have long felt uneasy about the figh trope they walked, trying to find the right balance between advising surgery for those men most likely to survive the cancer and counseling those with the slowest growing tumors to watch and wait. Fresh guidance came last year from a large Scandinavian study, in which men randomly assigned to undergo surgery produced by 50% their risk of drying from prostate cancer or having their cancer spread. It’s not clear, however, how this applies to American men. In the Scandinavian group. Most patients were found to have relatively advanced tumors, big enough be felt in a doctor’s manual exam. By contrast, in the U.S., 75% of men’s tumors are discovered by a blood test, which pick up cancers long before they become noticeable.